Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
We would like to use third party cookies and scripts to improve the functionality of this website.ApproveMore info